RSS

Pierre Fabre

Elsevier, an information analytics business, is working together with a set of evaluation partners including Boehringer Ingelheim, Eli Lilly and Company, Pierre Fabre, Sanofi, Servier, and others to develop a new DDIRC. Read more

News

Merck, Array BioPharma and Pierre Fabre have initiated a prospective, randomised, global phase three clinical trial for a treatment of BRAF-mutant metastatic colorectal cancer (mCRC) Read more

News

Pierre Fabre Laboratories is launching Nature Open Library, an Open Innovation programme Read more

News

Array BioPharma and Pierre Fabre have announced a collaboration to globally develop and commercialise Array's late-stage novel oncology products, binimetinib and encorafenib Read more

News